Calcium-regulated protein kinases and low Km cGMP phosphodiesterases: targets for novel antihypertensive therapy.
Silver
P J
PJ
Department of Cardiovascular Pharmacology, Sterling Research Group, Rensselaer, NY 12144.
Pagani
E D
ED
Cumiskey
W R
WR
Dundore
R L
RL
Harris
A L
AL
Lee
K C
KC
Ezrin
A M
AM
Buchholz
R A
RA
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000378:metabolism*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000201:enzymology; D009219:Myosin-Light-Chain Kinase / Q000378:metabolism; D011493:Protein Kinase C / Q000378:metabolism; D011494:Protein Kinases / Q000378:metabolism*
D000959:Antihypertensive Agents; D011494:Protein Kinases; D011493:Protein Kinase C; D009219:Myosin-Light-Chain Kinase; D015106:3',5'-Cyclic-GMP Phosphodiesterases